منابع مشابه
Prognostic Factors in Stage I Lung Cancer.
Lung cancer (LC) still has a very poor prognosis, with overall 5-year survival rates of 10%–20% in most countries.1 Nevertheless, the life expectancy of individual patients ranges widely, depending on specific circumstances: in non-small cell lung cancer (NSCLC), 5-year survival in stage IV disease is 2%–3%, but can be as high as 70% in stage I patients with fully resected disease.2 With regard...
متن کاملSurvival in untreated stage I lung cancer.
1. Vrdoljak et al 2 confi ned their SILC analysis to stage IB because there were too few cases of untreated stage IA to permit a valid assessment of survival. 2. They did not allocate deaths due to competing lethal morbidities (ie, overdiagnosed) vs those due to SILC. 3. They did not state that all people declining intervention underwent surgical mediastinal exploration (ie, some may have been ...
متن کاملPrognostic value of various metabolic parameters on pre-treatment 18-F-FDG PET/CT in patients with stage I-III non-small cell lung cancer
Background: the aim of this study was to investigate the prognostic value of 18Fluorine-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) parameters in both overall survival and progression-free survival in Stage I-III non-small cell lung cancer (NSCLC). Materials and Methods: In this retrospective study, 267 patients who were diagnosed as Stage I-III non-smal...
متن کاملOutcomes of accelerated hypofractionated radiotherapy in stage i non-small-cell lung cancer.
PURPOSE Outcomes after treatment with accelerated hypofractionated radiotherapy in stage i medically inoperable non-small-cell lung cancer (nsclc) patients were determined. METHODS Our single-institution retrospective review looked at medically inoperable patients with T1-2N0M0 nsclc treated with accelerated hypofractionated curative-intent radiotherapy between 1999 and 2009. Patients were st...
متن کاملTreatment of peripheral early stage lung cancer.
Not only is the incidence of lung cancer increasing around the world, this disease has become the leading cause of cancer death. Since lung cancer kills 85% to 90% of its victims, it is recognized as one of the most difficult to cure diseases. Although the therapeutic results are quite unsatisfactory as a whole, earlier stages of lung cancer, stages IA and IB show better therapeutic results (Ta...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Thoracic Oncology
سال: 2015
ISSN: 1556-0864
DOI: 10.1097/jto.0000000000000680